MEDPLUS HEALTH SERVICES Financial Statement Analysis
|
||
|
The Revenues of MEDPLUS HEALTH SERVICES have increased by 20.59% YoY .
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has increased by 31.41 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
MEDPLUS HEALTH SERVICES Last 5 Annual Financial Results
[BOM: 543427|NSE : MEDPLUS]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹4,558 Cr | ₹3,779 Cr | ₹3,069 Cr | ₹2,871 Cr | ₹2,273 Cr |
| Expenses | ₹4,276 Cr | ₹3,490 Cr | ₹2,840 Cr | ₹2,737 Cr | ₹2,216 Cr |
| Operating Profit (Excl OI) | ₹281 Cr | ₹289 Cr | ₹229 Cr | ₹134 Cr | ₹57 Cr |
| Other Income | ₹46 Cr | ₹31 Cr | ₹22 Cr | ₹17 Cr | ₹9.83 Cr |
| Interest | ₹99 Cr | ₹83 Cr | ₹67 Cr | ₹47 Cr | ₹16 Cr |
| Depreciation | ₹182 Cr | ₹119 Cr | ₹88 Cr | ₹75 Cr | ₹14 Cr |
| Profit Before Tax | ₹47 Cr | ₹118 Cr | ₹95 Cr | ₹29 Cr | ₹37 Cr |
| Profit After Tax | ₹50 Cr | ₹95 Cr | ₹63 Cr | ₹1.79 Cr | ₹21 Cr |
| Consolidated Net Profit | ₹50 Cr | ₹96 Cr | ₹64 Cr | ₹1.79 Cr | ₹21 Cr |
| Earnings Per Share (Rs) | ₹5.48 | ₹4.17 | ₹8.03 | ₹1,425.40 | ₹92.47 |
| PAT Margin (%) | 1.15 | 1.08 | 2.47 | 2.01 | 0.06 |
| ROE(%) | 4.36 | 3.50 | 9.07 | 10.51 | 0.43 |
| ROCE(%) | 12.19 | 9.56 | 16.56 | 21.69 | 14.34 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.10 | 0.20 | 0.20 |
Key Financials |
||
| Market Cap | : | ₹ 9,981.8 Cr |
| Revenue (TTM) | : | ₹ 5,997.0 Cr |
| Net Profit(TTM) | : | ₹ 100.3 Cr |
| EPS (TTM) | : | ₹ 8.4 |
| P/E (TTM) | : | 99.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MEDPLUS HEALTH SERVICES | -0.7% | 4% | 12.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.9% | 4.4% | 50% |
| CIPLA | 2.1% | 0.2% | 22.8% |
| DR REDDYS LABORATORIES | -1.1% | 12.1% | 18.1% |
| ZYDUS LIFESCIENCES | 1.8% | 0.9% | 41.3% |
| DIVIS LABORATORIES | 4.6% | -1.1% | 55.6% |
| MANKIND PHARMA | 0.9% | 13.3% | 45.6% |
| TORRENT PHARMACEUTICALS | 1.2% | 2.5% | 48.2% |
| LUPIN | 7.6% | 15.1% | 78.8% |
MEDPLUS HEALTH SERVICES Revenues
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 20.59 % |
| 5 Yr CAGR | 19.00 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹4,558 Cr | 20.59 | |
| Mar2023 | ₹3,779 Cr | 23.13 | |
| Mar2022 | ₹3,069 Cr | 6.92 | |
| Mar2021 | ₹2,871 Cr | 26.31 | |
| Mar2020 | ₹2,273 Cr | - | |
MEDPLUS HEALTH SERVICES Operating Profit
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | -2.60 % |
| 5 Yr CAGR | 49.18 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹281 Cr | -2.60 | |
| Mar2023 | ₹289 Cr | 26.03 | |
| Mar2022 | ₹229 Cr | 71.47 | |
| Mar2021 | ₹134 Cr | 135.34 | |
| Mar2020 | ₹57 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -19.24 % |
| 5 Yr CAGR | 25.34 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 6.17% | -19.24 | |
| Mar2023 | 7.64% | 2.28 | |
| Mar2022 | 7.47% | 60.30 | |
| Mar2021 | 4.66% | 86.40 | |
| Mar2020 | 2.5% | - | |
MEDPLUS HEALTH SERVICES Profit After Tax
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | -48.06 % |
| 5 Yr CAGR | 24.22 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹50 Cr | -48.06 | |
| Mar2023 | ₹96 Cr | 50.02 | |
| Mar2022 | ₹64 Cr | 3,459.53 | |
| Mar2021 | ₹1.79 Cr | -91.42 | |
| Mar2020 | ₹21 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 6.48 % |
| 5 Yr CAGR | 109.24 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 1.15 % | 6.48 | |
| Mar2023 | 1.08 % | -56.28 | |
| Mar2022 | 2.47 % | 22.89 | |
| Mar2021 | 2.01 % | 3,250.00 | |
| Mar2020 | 0.06 % | - | |
MEDPLUS HEALTH SERVICES Earnings Per Share (EPS)
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 31.41 % |
| 5 Yr CAGR | -50.66 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.48 | 31.41 | |
| Mar2023 | ₹4.17 | -48.07 | |
| Mar2022 | ₹8.03 | -99.44 | |
| Mar2021 | ₹1,425 | 1,441.47 | |
| Mar2020 | ₹92 | - | |
MEDPLUS HEALTH SERVICES Return on Capital Employed (ROCE)
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 27.51 % |
| 5 Yr CAGR | -3.98 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 12.19% | 27.51 | |
| Mar2023 | 9.56% | -42.27 | |
| Mar2022 | 16.56% | -23.65 | |
| Mar2021 | 21.69% | 51.26 | |
| Mar2020 | 14.34% | - | |
MEDPLUS HEALTH SERVICES Share Price vs Sensex
| Current Share Price | : | ₹833.9 |
| Current MarketCap | : | ₹ 9,981.8 Cr |
| Updated EOD on | : | Jan 02,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDPLUS HEALTH SERVICES | -0.7% |
4% |
12.9% |
| SENSEX | 1.9% |
-0.4% |
10.4% |
MEDPLUS HEALTH SERVICES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE CONSUMER DISC. | 3.1% | 1.8% | 28.6% |
| S&P BSE SMALL CAP | 2.3% | 0.8% | 32.4% |
| S&P BSE 400 MIDSMALLCAP | 1.8% | 0.8% | 28% |
| S&P BSE 250 SMALLCAP | 1.8% | 0.2% | 26.6% |
| S&P BSE 500 | 1.7% | -0.2% | 17% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 MULTICAP 50:25:25 | 1.8% | 0.3% | 21% |
You may also like the below Video Courses
FAQ about MEDPLUS HEALTH SERVICES Financials
How the annual revenues of MEDPLUS HEALTH SERVICES have changed ?
The Revenues of MEDPLUS HEALTH SERVICES have increased by 20.59% YoY .
How the Earnings per Share (EPS) of MEDPLUS HEALTH SERVICES have changed?
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has increased by 31.41 % YoY .
Check out Intrinsic Value of Peers of MEDPLUS HEALTH SERVICES
Compare Stock Analytics of Peers of MEDPLUS HEALTH SERVICES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
